Biotech

All Articles

Zephyrm finds Hong Kong IPO to fund stage 3 cell treatment trials

.Zephyrm Bioscience is actually gusting toward the Hong Kong stock exchange, declaring (PDF) for an ...

Frazier Lifestyle Sciences gets $630M for small, mid-cap biotechs

.Frazier Lifespan Sciences has actually sourced an additionally $630 thousand for its fund paid atte...

GigaGen achieves around $135M BARDA dollars to beat botulism

.Antitoxin aficionado GigaGen, a subsidiary of Spanish biopharma Grifols, is actually increase its o...

GPCR company Septerna apply for IPO on durability of preclinical data

.Septerna is about to learn just how a biotech without "any sort of meaningful professional data" fa...

Kurma shuts to begin with $154M haul for largest biotech fund yet

.International VC organization Kurma Partners has actually introduced its own most recent biotech fu...

Prothena ensures one director while an additional keeps-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our summary of substantial leadership hirings, shootings and...

Editas profit Vertex Cas9 licensing legal rights for $57M

.Versus the scenery of a Cas9 license struggle that refuses to perish, Editas Medication is actually...

Ultragenyx tweaks genetics therapy dosing to call up efficiency

.A minority of individuals taking Ultragenyx Pharmaceutical's Wilson ailment gene therapy UX701 have...

Biopharma unemployment fee maintains in Q3: Ferocious Biotech analysis

.As summer warmth counts on cool down winds, wishes that this year will bring wide-spread sector all...

J &amp J falls stage 2 dengue applicant in most recent switch coming from injections

.Johnson &amp Johnson's deprioritization of its own infectious disease pipe has asserted another tar...